Skip to main content

Disclaimer

In the Downloads section, the ‘Prior Submission’ file reflects the most recent measure submission to the former CBE. This file is provided for transparency. For any questions or clarification, please contact the designated measure steward.

Pharmacotherapy Management of COPD Exacerbation (PCE)

CBE ID
0549
Endorsement Status
1.0 New or Maintenance
1.1 Measure Structure
Previous Endorsement Cycle
Is Under Review
No
1.6 Measure Description

This measure assesses the percentage of COPD exacerbations for members 40 years of age and older who had an acute inpatient discharge or ED encounter on or between January 1–November 30 of the measurement year and who were dispensed appropriate medications.

Two rates are reported.
1. Dispensed a systemic corticosteroid within 14 days of the event
2. Dispensed a bronchodilator within 30 days of the event

Note: The eligible population for this measure is based on acute inpatient discharges and ED visits, not on members. It is possible for the denominator to include multiple events for the same individual.

    Measure Specs
      General Information
      1.7 Measure Type
      1.3 Electronic Clinical Quality Measure (eCQM)
      No
      1.20 Types of Data Sources
      1.14 Numerator

      This measure looks at the number of patients with an acute exacerbation related to COPD who were discharged and were dispensed medications following the discharge with appropriate medications. Two rates are reported for the numerator.
      Rate 1: Dispensed prescription for systemic corticosteroid (Table PCE-C) on or 14 days after the Episode Date.
      Rate 2: Dispensed prescription for a bronchodilator (Table PCE-D) on or 30 days after the Episode Date.

      1.15 Denominator

      The eligible population for the measure includes all health plan members 40 years or older as of January 1 of the measurement year discharged from an inpatient setting (acute inpatient or ED) with a principal diagnosis of COPD

      Exclusions

      1) Exclude any episodes on which the patient was transferred directly to an acute or nonacute care facility for any diagnosis.
      2) Exclude inpatient ED Episodes on which the patient was readmitted to an acute or nonacute care facility for any diagnosis on or seven days after discharge.

      Most Recent Endorsement Activity
      Measure Retired and Endorsement Removed Pulmonary Endorsement Maintenance Project
      Initial Endorsement
      Last Updated
      Removal Date
      Steward Organization
      National Committee for Quality Assurance
      Steward POC email
      Steward Organization Copyright

      © 2012 by the National Committee for Quality Assurance
      1100 13th Street, NW, Suite 1000
      Washington, DC 20005

                Public Comments